HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen, Baka.

Abstract
Post-transfusion purpura (PTP) with severe thrombocytopenia occurred eight days after transfusion in a 28-year-old woman and responded to treatment with prednisone and plasma exchange. In contrast to nearly all previously studied cases of PTP, the patient's platelets were PlA1-positive and anti-PlA1 antibody could not be detected in serum obtained during the thrombocytopenic episode. Her serum was found to contain an antibody specific for a recently described platelet-specific alloantigen, Baka, in addition to multiple HLA-specific antibodies. The patient's platelets, typed following recovery, were Baka-negative. These findings indicate that post-transfusion purpura can occur in association with alloimmunization to platelet-specific antigens other than PlA1. In performing the serologic studies, a close relationship and possible identity between Baka and another recently reported platelet antigen, Leka, was observed. A method for analyzing mixtures of cytotoxic platelet-reactive antibodies without separating the individual antibodies is described.
AuthorsR M Keimowitz, J Collins, K Davis, R H Aster
JournalAmerican journal of hematology (Am J Hematol) Vol. 21 Issue 1 Pg. 79-88 (Jan 1986) ISSN: 0361-8609 [Print] United States
PMID3754690 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • 3a alloantigen, human
  • Antigens, Human Platelet
  • HLA Antigens
  • ITGB3 protein, human
  • Integrin beta3
  • Isoantibodies
  • Isoantigens
Topics
  • Adult
  • Antigens, Human Platelet
  • Blood Group Incompatibility (immunology)
  • Blood Platelets (immunology)
  • Female
  • HLA Antigens (immunology)
  • Humans
  • Integrin beta3
  • Isoantibodies (analysis)
  • Isoantigens (immunology)
  • Platelet Transfusion
  • Purpura, Thrombocytopenic (etiology, immunology)
  • Time Factors
  • Transfusion Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: